Functional Characterization of the Bladder Cancer Marker, BLCA-4

Clinical Cancer Research

Volumn 10, Issue 4, 2004, Pages 1384-1391

  Van Le, Thu Suong ^a   Myers, Julie ^a   Konety, Badrinath R ^b   Barder, Timothy ^c   Getzenberg, Robert H ^a,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c Eprogen Inc   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROTEIN BLCA 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CELL GROWTH; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GROWTH RATE AND GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS; BETA-GALACTOSIDASE; CARCINOGENS; CELL NUCLEUS; CLINICAL TRIALS; CLONING, MOLECULAR; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA, COMPLEMENTARY; FEMALE; HUMANS; IMMUNOBLOTTING; METHYLNITROSOUREA; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, INBRED F344; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SEQUENCE HOMOLOGY, AMINO ACID; TISSUE DISTRIBUTION; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 1642361625     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-0455-03     Document Type: Article

References (15)

1. American Cancer Society. Cancer Facts and Figures: 2003. Washington, DC: American Cancer Society, 2003.
2. Mostafi, F. K., Davis, C. J., and Sesterhenn, I. A. Pathology of tumors of the urinary tract. In: D. G. Skinner and G. Lieskovsky (eds.), Diagnosis and Management of Genitourinary Cancer, pp. 83-117. Philadelphia: Saunders, 1988.
3. Lower, G. M. Concepts in casualty: chemically induced human bladder cancer. Cancer (Phila.), 49: 1056, 1982.
4. Murphy, W. M., and Soloway, M. S. Urothelial dysplasia. J. Urol., 127: 849-854, 1982.
5. Getzenberg, R. H., Konety, B. R., Oeler, T. A., Quigley, M. M., Hakam, A., Becich, M. J., and Bahnson, R. R. Bladder cancer-associated nuclear matrix proteins. Cancer Res., 56: 1690-1694, 1996.
6. Konety, B. R., Nguyen, T-S. T., Lavelle, J. P., Zeidel, M. L., and Getzenberg, R. H. Expression of BLCA-4, a nuclear matrix protein (NMP) marker in a carcinogen induced model of bladder cancer. J. Urol., 163 (Suppl.): abstract 597, 2000.
7. Konety, B. R., Nguyen, T-S, Dhir, R., Becich, M. J., Stadler, W. M., and Getzenberg, R. H. Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4. Clin. Cancer Res., 6: 2618-2625, 2000.
8. Hicks, R. M., and Wakefield, J. Rapid induction of bladder cancer in rats with N-methyl-N-nitrosurea I. Histol. Chem. Biol. Interact., 5: 139-152, 1972.
9. Hicks, R. M., and Wakefield, J. Membrane changes during urothelial hyperplasia and neoplasia. Cancer Res., 36: 2502-2507, 1976.
10. Steinberg, G. D., Brendler, C. B., Ichikawa, T., Squire, R. A., and Issacs, J. T. Characterization of an N-methyl-N-nitrosurea induced autochthonous rat bladder cancer model. Cancer Res., 50: 6668-6674, 1990.
11. Raghavan, D., Debruyne, F., Herr, H., Jocham, D., Kakizoe, T., Okajime, E., Sandberg, A., and Tannock, I. Experimental models of bladder cancer: a critical review. Prog. Clin. Biol. Res., 171: 208, 1986.
12. Wasylyk, B., Hanh, S. L., and Giovane, A. The Ets family of transcription factors, review. Eur. J. Biochem., 211: 7-18, 1993.
13. Rao, V. N., Huebner, K., Isobe, M. Ar-Rushdi, A., Croce, D. M., and Reddy, E. S. P. Elk, tissue-specific ets-related genes on chromosomes X and 14 near translocation breakpoints. Science (Wash. DC), 244: 66-70, 1989.
14. Mavrothalassitis, G., and Ghysdael, J. Proteins of the ETS family with transcriptional repressor activity, review. Oncogene, 19: 6524-6532, 20001.
15. Soloway, M. S., Briggman, J. V., Carpinto, G. A., Chodok, G. W., Church, P. A., Lamm, D. L., Lange, P., Messing, E., Pasciak, R. M., Reservitz, G. B., et al. Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J. Urol., 156: 363-367, 1996.